These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29941355)

  • 1. Glucocorticoid-Induced Osteoporosis: Management Challenges in Older Patients.
    Adler RA
    J Clin Densitom; 2019; 22(1):20-24. PubMed ID: 29941355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
    Chotiyarnwong P; McCloskey EV
    Nat Rev Endocrinol; 2020 Aug; 16(8):437-447. PubMed ID: 32286516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-induced osteoporosis: pathophysiology and therapy.
    Canalis E; Mazziotti G; Giustina A; Bilezikian JP
    Osteoporos Int; 2007 Oct; 18(10):1319-28. PubMed ID: 17566815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.
    Mazziotti G; Giustina A; Canalis E; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1404-12. PubMed ID: 18209880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of glucocorticoid-induced osteoporosis.
    Compston J
    Nat Rev Rheumatol; 2010 Feb; 6(2):82-8. PubMed ID: 20125175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucocorticoid-induced osteoporosis : treatment update].
    Soen S
    Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced osteoporosis: an update on effects and management.
    Buehring B; Viswanathan R; Binkley N; Busse W
    J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.
    Boling EP
    Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E; Walker-Bone K
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-induced osteoporosis: an update.
    Compston J
    Endocrine; 2018 Jul; 61(1):7-16. PubMed ID: 29691807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis.
    Chiodini I; Falchetti A; Merlotti D; Eller Vainicher C; Gennari L
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):283-298. PubMed ID: 32584619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
    Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucocorticoid-induced osteoporosis].
    Tóth M; Tulassay Z
    Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Glucocorticoid-Induced Osteoporosis: Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting.
    Carter M
    J Clin Densitom; 2019; 22(1):25-30. PubMed ID: 29729949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical question: What is the best approach to managing glucocorticoid-induced osteoporosis?
    Compston J
    Clin Endocrinol (Oxf); 2011 May; 74(5):547-50. PubMed ID: 21470278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.